The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EGFR ligands and ERCC1 mRNA expression to predict clinical outcome in Japanese (JPN) patients (pts) with metastatic colorectal cancer (mCRC) harboring overexpressed EGFR and KRAS exon 2 wild-type (KRAS wt) treated with cetuximab (cet) plus oxaliplatin-based chemotherapy (JACCRO CC-05/06 AR).
 
Yu Sunakawa
Honoraria - Takeda
 
Wataru Ichikawa
Honoraria - Bristol-Myers Squibb; Merck Serono; Taiho Pharmaceutical
Consulting or Advisory Role - Daiichi Sankyo; Merck Serono
 
Akihito Tsuji
Honoraria - Taiho Pharmaceutical
 
Miriana Moran
Employment - Response Genetics
Leadership - Response Genetics
Stock and Other Ownership Interests - CytRx Corporation; Galena Biopharma; Peregrine Pharmaceuticals; Vivus
 
Stephanie H. Astrow
Employment - Response Genetics
Leadership - Response Genetics
Stock and Other Ownership Interests - Response Genetics
 
Dongyun Yang
No Relationships to Disclose
 
Wu Zhang
No Relationships to Disclose
 
Takehiro Takahashi
No Relationships to Disclose
 
Tadamichi Denda
No Relationships to Disclose
 
Ken Shimada
No Relationships to Disclose
 
Mitsugu Kochi
No Relationships to Disclose
 
Masato Nakamura
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Masahito Kotaka
No Relationships to Disclose
 
Yoshihiko Segawa
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Masahiro Takeuchi
Honoraria - Takeda
Consulting or Advisory Role - AstraZeneca; Hisamitsu Pharmaceutical; Shionogi; Taiho Pharmaceutical
 
Heinz-Josef Lenz
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Merck KGaA; Vela Diagnostics
Research Funding - Bristol-Myers Squibb; Genentech; Merck KGaA; Novartis
 
Masashi Fujii
Stock and Other Ownership Interests - Otsuka (I)
Consulting or Advisory Role - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization
 
Toshifusa Nakajima
No Relationships to Disclose